Company profile
Evotec SE
NASDAQ:EVOBiotechnology: Pharmaceutical Preparations
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT06943378 | phase1 | active_not_recruiting | 2025-05-16 | 2027-04-01 | Just-Evotec Biologics | Ph1, Randomized, Double-Blind and Controlled, Dose Escalation and Expansion Study to Assess the Safety and Pharmacokinetics of JST-010 in Healthy Adults |
| NCT07595458 | phase1 | recruiting | 2026-06-23 | 2026-11-09 | Just-Evotec Biologics | Phase 1 Study on the Safety, Tolerability, and Pharmacokinetics of JST-018 in Healthy Adults |
FDA applications (0)
No records yet.